News, Events, Publications and Presentations

46 Items
16th Sep 2026

Yaqrit announces completion of final patient visit in CATCh study of YAQ001 in PSC and IBD
13th Jul 2026

First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure
17th Apr 2026

Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
16th Mar 2026

YAQRIT Winter Newsletter
21st Dec 2025

NHS to trial potentially life-saving treatment for deadly liver disease
3rd Dec 2025

First patient treated in PSC trial
20th Nov 2025

YAQRIT Autumn Newsletter
12th Nov 2025

First patient dosed in a proof-of-concept study of Yaqrit’s advanced microbiome therapeutic YAQ001 in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
7th Nov 2025

AASLD 2025: Dynamic changes in the a-tango organ failure score over 7-days accurately defines mortality and could be used as a surrogate end point in clinical trials
1 2 3 … 6

Our Companies

Therapeutic for acute-on-chronic liver failure

Extracorporeal liver support for acute-on-chronic liver failure

Advanced microbiome therapeutic to restore gut health

Treatment and prevention of recurrence of hepatic encephalopathy